Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts

Circulation

Volumn 100, Issue 22, 1999, Pages 2260-2266

  Csonka, Csaba ^a,c   Szilvássy, Zoltán ^a   Fülöp, Ferenc ^a   Páli, Tibor ^b   Blasig, Ingolf E ^c   Tosaki, Arpad ^a   Schulz, Richard ^d   Ferdinandy, Péter ^a,d,e  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Electron spin resonance; Ischemia; Nitric oxide; Preconditioning; Reperfusion

Indexed keywords

N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; ELECTRON SPIN RESONANCE; HEART FUNCTION; ISCHEMIC HEART DISEASE; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0344146411     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.22.2260     Document Type: Article

References (35)

1. Ferdinandy P, Szilvassy Z, Baxter GF. Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci. 1998;19:223-229.
2. Baxter GF, Yellon DM. Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection. Br J Clin Pharmacol. 1994;38:381-387.
3. Baxter GF, Marber MS, Yellon DM. Myocardial stress response, cytoprotective proteins and the second window of protection against infarction. In: Wainwright CL, Parratt JR, eds. Myocardial Preconditioning. Georgetown, Tex: RG Landes Co; 1996:233-250.
4. Ferdinandy P, Szilvassy Z, Koltai M, Dux L. Ventricular overdrive pacing-induced preconditioning and no-flow ischemia-induced preconditioning in isolated working rat hearts. J Cardiovasc Pharmacol. 1995;25:97-104.
5. Parratt JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci. 1994;15:19-25.
6. Balligand JL, Cannon PJ. Nitric oxide synthases and cardiac muscle: autocrine and paracrine influences. Arterioscler Thromb Vasc Biol. 1997;17:1846-1858.
7. Depre C, Fierain L, Hue L. Activation of nitric oxide synthase by ischaemia in the perfused heart. Cardiovasc Res. 1997;33:82-87.
8. Zweier JL, Wang P, Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem. 1995;270:304-307.
9. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res. 1995;30:432-439.
10. Yasmin W, Strynadka KD, Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res. 1997;33:422-432.
11. Vegh A, Szekeres L, Parratt J. Preconditioning of the ischaemic myocardium: involvement of the L-arginine nitric oxide pathway. Br J Pharmacol. 1992;107:648-652.
12. Ferdinandy P, Szilvassy Z, Horvath LI, Csont T, Csonka C, Nagy E, Szentgyörgyi R, Nagy I, Koltai M, Dux L. Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol. 1997;29:3321-3333.
13. Ferdinandy P, Csont T, Csonka C, Torok M, Dux M, Nemeth J, Horvath LI, Dux L, Szilvassy Z, Jancso G. Capsaicin-sensitive local sensory innervation is involved in pacing-induced preconditioning in rat hearts: role of nitric oxide and CGRP? Naunyn Schmiedebergs Arch Pharmacol. 1997;356:356-363.
14. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, Zhang Q, Jadoon AK. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res. 1997;81:1094-1107.
15. Bolli R, Bhatti ZA, Tang XL, Qiu YM, Zhang Q, Guo Y, Jadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 1997;81:42-52.
16. Ferdinandy P, Szilvassy Z, Csont T, Csonka C, Nagy E, Koltai M, Dux L. Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. Br J Pharmacol. 1995;115:1129-1131.
17. Bouma P, Ferdinandy P, Sipkema P, Westerhof N. Nitric oxide is an important determinant of coronary blood flow in the isolated blood perfused rat heart. Basic Res Cardiol. 1992;87:570-584.
18. Mülsch A, Mordvintcev P, Vanin A. Quantification of nitric oxide in biological samples by electron spin resonance spectroscopy. Neuroprotocols. 1992;1:165-173.
19. Ferdinandy P, Das DK, Tosaki A. Pacing-induced ventricular fibrillation leading to oxygen free radical formation in aerobically perfused rat heart. J Mol Cell Cardiol. 1993;25:683-692.
20. Shinobu LA, Jones SG, Jones RM. Sodium W-methyl-D-glucamine dithiocarbamate and cadmium intoxication. Acta Pharmacol Toxicol. 1984;54:189-194.
21. Csont T, Pali T, Szilvassy Z, Ferdinandy P. Lack of correlation between myocardial nitric oxide and cyclic guanosine monophosphate content in both nitrate-tolerant and nontolerant rats. Biochem Pharmacol. 1998;56:1139-1144.
22. Zweier JL, Wang P, Samuilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med. 1995;1:804-809.
23. Depre C, Hue L. Cyclic GMP in the perfused rat heart: effect of ischaemia, anoxia and nitric oxide synthase inhibitor. FEBS Lett. 1994;345:241-245.
24. Kitakaze M, Node K, Komamura K, Minamino T, Inoue M, Hon M, Kamada T. Evidence for nitric oxide generation in cardiomyocytes: its augmentation by hypoxia. J Mol Cell Cardiol. 1995;27:2149-2154.
25. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Inoue M, Tada M, Hori M, Kamada T. Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. Circulation. 1996;93:356-364.
26. Woolfson RG, Patel VC, Neild GH, Yellon DM. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation. 1995;91:1545-1551.
27. Hasebe N, Shen Y-T, Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation. 1993;88:2862-2871.
28. Lefer AM, Siegfried MR, Ma X. Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J Cardiovasc Pharmacol. 1993;22(suppl 7):S27-S33.
29. Curtis MJ, Pabla R. Nitric oxide supplementation or synthesis block: which is the better approach to treatment of heart disease? Trends Pharmacol Sci. 1997;18:239-244.
30. Weselcouch EO, Baird AJ, Sleph P, Grover GJ. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol. 1995;268:H242-H249.
31. Wang PH, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem. 1996;271:29223-29230.
32. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad and the ugly. Am J Physiol. 1996;271:C1424-C1437.
33. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation: formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem. 1994;269:26066-26075.
34. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-575.
35. Lu HR, Remeysen P, De Clerck F. Does the antiarrhythmic effect of ischemic preconditioning in rats involve the L-arginine nitric oxide pathway? J Cardiovasc Pharmacol. 1995;25:524-530.